- Home
- KRRO vs MCN Comparison
KRRO vs MCN Comparison
Compare KRRO & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- MCN
- Stock Information
- Founded
- KRRO 2014
- MCN 2004
- Country
- KRRO United States
- MCN Canada
- Employees
- KRRO N/A
- MCN N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- MCN
- Sector
- KRRO Health Care
- MCN
- Exchange
- KRRO Nasdaq
- MCN Nasdaq
- Market Cap
- KRRO 147.4M
- MCN 127.3M
- IPO Year
- KRRO 2019
- MCN N/A
- Fundamental
- Price
- KRRO $33.22
- MCN $6.21
- Analyst Decision
- KRRO Strong Buy
- MCN
- Analyst Count
- KRRO 7
- MCN 0
- Target Price
- KRRO $96.71
- MCN N/A
- AVG Volume (30 Days)
- KRRO 237.0K
- MCN 52.9K
- Earning Date
- KRRO 11-11-2025
- MCN 01-01-0001
- Dividend Yield
- KRRO N/A
- MCN 9.96%
- EPS Growth
- KRRO N/A
- MCN N/A
- EPS
- KRRO N/A
- MCN N/A
- Revenue
- KRRO $6,281,000.00
- MCN N/A
- Revenue This Year
- KRRO $97.27
- MCN N/A
- Revenue Next Year
- KRRO N/A
- MCN N/A
- P/E Ratio
- KRRO N/A
- MCN N/A
- Revenue Growth
- KRRO N/A
- MCN N/A
- 52 Week Low
- KRRO $10.29
- MCN $6.69
- 52 Week High
- KRRO $98.00
- MCN $8.60
- Technical
- Relative Strength Index (RSI)
- KRRO 67.72
- MCN 46.04
- Support Level
- KRRO $30.36
- MCN $6.15
- Resistance Level
- KRRO $37.03
- MCN $6.27
- Average True Range (ATR)
- KRRO 3.68
- MCN 0.05
- MACD
- KRRO -0.07
- MCN -0.01
- Stochastic Oscillator
- KRRO 77.36
- MCN 32.35
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About MCN Madison Covered Call & Equity Strategy Fund
XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.